Project Umbrella Translation
ABOUT PLAGA "TYPE 2"
The "Plaga", discovered in a desolate European village, has a trait of controlling hosts through parasitism. By employing this trait, the goal of commercializing this Plaga is to create soldiers loyal to commands.
However, there's one problem with commercializing it. After administering the Plaga into a host's body, there's an inevitable time lag before it takes over the mind.
This is a result of the Plaga being administered in an egg state, and therefore requires time to hatch, grow, then attach to the central nervous system.
Although the Plaga's growth is by no means slow, many of our customers are impatient. If it doesn't work "immediately" when needed, we can't expect it to succeed as a product.
That's why we've developed an improved Plaga model. We're calling this improved version "Plaga Type 2." This Type 2 is characterized by immediate control of the mind as a result of directly administering an already mature Plaga.
The dosing method is oral administration. In other words, it's forced into the mouth.
Though it may be a crude method, sometimes the simplest approach is the best. An orally administered Type 2 invades the body by tearing through the esophagus, starting by parasitizing the medulla oblongata before progressing to the central nervous system such as the spine and brain, where it begins to control the mind.
In laboratory experiments, we recorded a time average of ten or less seconds between administering Type 2 and the mind being controlled. We have verified it also possesses the characteristics of the original Plaga species.
Simply with performance like this, it'd be sufficiently marketable as a product.
Although the task of accumulating practical application data remains, we'll conduct this in the Kijuju Autonomous Zone.
The experiment items are the following three points.
1. Infection
Limit primary administration of Type 2 to ten pairs of test subjects and observe and study speed of subsequent spread of infection. Therefore, the first ten subjects will be issued a sufficient quantity of Type 2 beforehand.
2. Control
Test to see to what extent we can suppress the ferocity the Plaga induces in a carrier. We hope this will have the simultaneous effect of leading BSAA personnel deeper into the urban area, so that we may conduct the third experiment more smoothly.
3. Combat
Accumulate data on Type 2's combat performance. BSAA personnel dispatched in the field will be the combat targets.
The above experiment will be the final evaluating test for Plaga Type 2.
The "Plaga", discovered in a desolate European village, has a trait of controlling hosts through parasitism. By employing this trait, the goal of commercializing this Plaga is to create soldiers loyal to commands.
However, there's one problem with commercializing it. After administering the Plaga into a host's body, there's an inevitable time lag before it takes over the mind.
This is a result of the Plaga being administered in an egg state, and therefore requires time to hatch, grow, then attach to the central nervous system.
Although the Plaga's growth is by no means slow, many of our customers are impatient. If it doesn't work "immediately" when needed, we can't expect it to succeed as a product.
That's why we've developed an improved Plaga model. We're calling this improved version "Plaga Type 2." This Type 2 is characterized by immediate control of the mind as a result of directly administering an already mature Plaga.
The dosing method is oral administration. In other words, it's forced into the mouth.
Though it may be a crude method, sometimes the simplest approach is the best. An orally administered Type 2 invades the body by tearing through the esophagus, starting by parasitizing the medulla oblongata before progressing to the central nervous system such as the spine and brain, where it begins to control the mind.
In laboratory experiments, we recorded a time average of ten or less seconds between administering Type 2 and the mind being controlled. We have verified it also possesses the characteristics of the original Plaga species.
Simply with performance like this, it'd be sufficiently marketable as a product.
Although the task of accumulating practical application data remains, we'll conduct this in the Kijuju Autonomous Zone.
The experiment items are the following three points.
1. Infection
Limit primary administration of Type 2 to ten pairs of test subjects and observe and study speed of subsequent spread of infection. Therefore, the first ten subjects will be issued a sufficient quantity of Type 2 beforehand.
2. Control
Test to see to what extent we can suppress the ferocity the Plaga induces in a carrier. We hope this will have the simultaneous effect of leading BSAA personnel deeper into the urban area, so that we may conduct the third experiment more smoothly.
3. Combat
Accumulate data on Type 2's combat performance. BSAA personnel dispatched in the field will be the combat targets.
The above experiment will be the final evaluating test for Plaga Type 2.
Official Japanese Transcript
"タイプ2"プラーガについて
ヨーロッパの寒村で発見された「プラーガ」には、寄生により宿主をコントロールするという特徴がある。この特徴を用いることにより、命令に忠実な兵士を作り出すというのが、このプラーガ商品化の狙いである。
しかし、商品化には一つの問題があった。プラーガは、宿主の体内に投与してから精神を支配するまでの間に、絶対的なタイムラグが存在するのだ。
これはプラーガが卵の状態で投与されるため、ふ化して成長し、中枢神経に取り付くまでにどうしても時間が必要なためである。
プラーガの成長は決して遅くはないが、我々の顧客にはせっかちな人間が多い。必要な時に、"すぐに"効果がないと、商品としての成功は望めないだろう。
そこで改良型のプラーガが開発された。我々は、この改良型を「プラーガ・タイプ2」と呼んでいる。タイプ2では、すでに成長したプラーガを直接投与するため、精神の支配が即時に行われるという特徴がある。
投与の方法は、経口投与。つまりは、口から無理やり押し込むわけだ。
荒っぽい方法だが、時にはシンプルな方法が一番のこともある。経口投与されたタイプ2は、食堂を破って体内に侵入し、延髄を手始めに、脳、脊髄などの中枢神経に寄生、精神の支配を始める。
研究室内での実験では、タイプ2の投与から精神が支配されるまで、平均10秒以下というタイムを記録している。また、原種プラーガが持っていた特徴も併せ持っていることが確認された。
これだけの性能があれば、まずは商品として十分に売り物になるだろう。
残るは実用データの蓄積だが、これはキジュジュ自治区で行うことにする。
実験項目は以下の3点である。
1.感染
タイプ2の一次投与は10対の被験者に留め、その後の感染の拡散スピードを観察、調査する。そのため、最初の10名の被験者には、あらかじめ十分な量のタイプ2を渡しておく。
2.抑制
プラーガが感染者にもたらす凶暴性を、どこまで抑制することができるかを実験する。これには、同時にBSAA隊員を市街地深部まで誘導し、3番の実験をスムーズに行うための効果も期待する。
3.戦闘
タイプ2の戦闘能力に関するデータを蓄積する。戦闘対象は、現地に出動してきたBSAAの隊員とする。
以上の実験をもって、プラーガ・タイプ2の最終評価試験とする。
ヨーロッパの寒村で発見された「プラーガ」には、寄生により宿主をコントロールするという特徴がある。この特徴を用いることにより、命令に忠実な兵士を作り出すというのが、このプラーガ商品化の狙いである。
しかし、商品化には一つの問題があった。プラーガは、宿主の体内に投与してから精神を支配するまでの間に、絶対的なタイムラグが存在するのだ。
これはプラーガが卵の状態で投与されるため、ふ化して成長し、中枢神経に取り付くまでにどうしても時間が必要なためである。
プラーガの成長は決して遅くはないが、我々の顧客にはせっかちな人間が多い。必要な時に、"すぐに"効果がないと、商品としての成功は望めないだろう。
そこで改良型のプラーガが開発された。我々は、この改良型を「プラーガ・タイプ2」と呼んでいる。タイプ2では、すでに成長したプラーガを直接投与するため、精神の支配が即時に行われるという特徴がある。
投与の方法は、経口投与。つまりは、口から無理やり押し込むわけだ。
荒っぽい方法だが、時にはシンプルな方法が一番のこともある。経口投与されたタイプ2は、食堂を破って体内に侵入し、延髄を手始めに、脳、脊髄などの中枢神経に寄生、精神の支配を始める。
研究室内での実験では、タイプ2の投与から精神が支配されるまで、平均10秒以下というタイムを記録している。また、原種プラーガが持っていた特徴も併せ持っていることが確認された。
これだけの性能があれば、まずは商品として十分に売り物になるだろう。
残るは実用データの蓄積だが、これはキジュジュ自治区で行うことにする。
実験項目は以下の3点である。
1.感染
タイプ2の一次投与は10対の被験者に留め、その後の感染の拡散スピードを観察、調査する。そのため、最初の10名の被験者には、あらかじめ十分な量のタイプ2を渡しておく。
2.抑制
プラーガが感染者にもたらす凶暴性を、どこまで抑制することができるかを実験する。これには、同時にBSAA隊員を市街地深部まで誘導し、3番の実験をスムーズに行うための効果も期待する。
3.戦闘
タイプ2の戦闘能力に関するデータを蓄積する。戦闘対象は、現地に出動してきたBSAAの隊員とする。
以上の実験をもって、プラーガ・タイプ2の最終評価試験とする。
Official English Transcript
"Due to errors or changes in localization, the following may contain inconsistencies with the official Japanese text."
TYPE 2 PLAGAS
As stated in earlier documentation on the subject, the original Las Plagas parasite was discovered in an isolated area in Europe. Upon maturation in a host, the parasite quickly replaces the host's will and self-awareness, rendering them highly
susceptible to control by another.
It was this aspect of Las Plagas that meant one so inclined could create obedient subjects who would obey directives without question. With obvious commercial application possibilities, Las Plagas quickly came under review by interested parties.
The problem with commercializing Las Plagas was the time discrepancy between initial infection and when the hosts were rendered susceptible to control.
The time between when Las Plagas is administered to the host as an egg and the time when it fully matures and attaches itself to the control nervous system was met with negative criticism.
The maturation cycle of Las Plagas is relatively bred, but potential customers wishing for more expedient results.
With this in mind, research was undertaken to improve Las Plagas. The final result of this research becoming Type 2 Plagas.
Type 2 Plagas differs from its predecessor in that it is administered in its mature state, and from that point the host can almost immediately be controlled.
Type 2 is administered orally, or more specifically, it is forced into the mouth of the host. It's an indelicate method, but it's also the most effective.
After oral administration, Type 2 rends the esophagus and moves first to the medulla oblongata, then to the brain proper, and and finally the spinal cord. Once it has taken hold of the central nervous system, the host can be controlled.
Under a laboratory setting, we recorded complete control of a host within ten seconds of administration of Type 2.
Aside from the reduced infection time, the Type 2 Plagas appeared to share all of the characteristics of the original Las Plagas, which made it more than suitable for commercialization.
All that remains now is to simulate field data from the Kijuju Autonomous Zone.
Listed below are the three key experiments for evaluation of Type 2:
1. Infection
Administer Type 2 samples to 10 previously infected individuals and observe the rate at which they spread the infection. These 10 test subjects must be given enough Type 2 to create measurable results.
2. Control
Observe to what extent the barbaric behavior induced by the Plagas can be controlled. This will be
ascertained by witnessing the results of the directive to engage the BSAA operatives within the area.
3. Fighting
Accumulate data on Type 2 in combat. Type 2 hosts will battle BSAA operatives deployed in the area.
This experiment will be the last stage for evaluating the effectiveness of Type 2 Plagas.
TYPE 2 PLAGAS
As stated in earlier documentation on the subject, the original Las Plagas parasite was discovered in an isolated area in Europe. Upon maturation in a host, the parasite quickly replaces the host's will and self-awareness, rendering them highly
susceptible to control by another.
It was this aspect of Las Plagas that meant one so inclined could create obedient subjects who would obey directives without question. With obvious commercial application possibilities, Las Plagas quickly came under review by interested parties.
The problem with commercializing Las Plagas was the time discrepancy between initial infection and when the hosts were rendered susceptible to control.
The time between when Las Plagas is administered to the host as an egg and the time when it fully matures and attaches itself to the control nervous system was met with negative criticism.
The maturation cycle of Las Plagas is relatively bred, but potential customers wishing for more expedient results.
With this in mind, research was undertaken to improve Las Plagas. The final result of this research becoming Type 2 Plagas.
Type 2 Plagas differs from its predecessor in that it is administered in its mature state, and from that point the host can almost immediately be controlled.
Type 2 is administered orally, or more specifically, it is forced into the mouth of the host. It's an indelicate method, but it's also the most effective.
After oral administration, Type 2 rends the esophagus and moves first to the medulla oblongata, then to the brain proper, and and finally the spinal cord. Once it has taken hold of the central nervous system, the host can be controlled.
Under a laboratory setting, we recorded complete control of a host within ten seconds of administration of Type 2.
Aside from the reduced infection time, the Type 2 Plagas appeared to share all of the characteristics of the original Las Plagas, which made it more than suitable for commercialization.
All that remains now is to simulate field data from the Kijuju Autonomous Zone.
Listed below are the three key experiments for evaluation of Type 2:
1. Infection
Administer Type 2 samples to 10 previously infected individuals and observe the rate at which they spread the infection. These 10 test subjects must be given enough Type 2 to create measurable results.
2. Control
Observe to what extent the barbaric behavior induced by the Plagas can be controlled. This will be
ascertained by witnessing the results of the directive to engage the BSAA operatives within the area.
3. Fighting
Accumulate data on Type 2 in combat. Type 2 hosts will battle BSAA operatives deployed in the area.
This experiment will be the last stage for evaluating the effectiveness of Type 2 Plagas.